X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10891) 10891
Book Review (2899) 2899
Publication (762) 762
Magazine Article (52) 52
Conference Proceeding (22) 22
Book Chapter (17) 17
Dissertation (6) 6
Book / eBook (4) 4
Paper (4) 4
Web Resource (3) 3
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10180) 10180
index medicus (10016) 10016
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (6271) 6271
male (5425) 5425
female (4955) 4955
statins (4605) 4605
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (4171) 4171
middle aged (4068) 4068
aged (3571) 3571
risk factors (2675) 2675
cholesterol (2199) 2199
cardiac & cardiovascular systems (2190) 2190
abridged index medicus (2149) 2149
treatment outcome (2121) 2121
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (2006) 2006
adult (1999) 1999
pharmacology & pharmacy (1899) 1899
simvastatin (1707) 1707
atorvastatin (1682) 1682
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (1467) 1467
animals (1442) 1442
cholesterol, ldl - blood (1432) 1432
risk (1393) 1393
medicine, general & internal (1371) 1371
hypercholesterolemia - drug therapy (1306) 1306
cardiovascular diseases - prevention & control (1263) 1263
prevention (1255) 1255
therapy (1245) 1245
cardiovascular disease (1236) 1236
drug therapy (1172) 1172
mortality (1098) 1098
coronary-heart-disease (1088) 1088
atorvastatin calcium (1061) 1061
pravastatin (1058) 1058
aged, 80 and over (1031) 1031
analysis (965) 965
cardiovascular (952) 952
statin (952) 952
atherosclerosis (941) 941
drug therapy, combination (938) 938
peripheral vascular disease (938) 938
lipids (925) 925
anticholesteremic agents - therapeutic use (919) 919
time factors (906) 906
care and treatment (888) 888
retrospective studies (849) 849
hypercholesterolemia (842) 842
cardiovascular agents (815) 815
myocardial-infarction (804) 804
cardiovascular diseases (800) 800
risk assessment (791) 791
research (772) 772
cardiovascular-disease (771) 771
medicine & public health (759) 759
cardiology (757) 757
randomized controlled trials as topic (754) 754
dose-response relationship, drug (753) 753
metaanalysis (747) 747
disease (729) 729
prospective studies (720) 720
c-reactive protein (716) 716
rosuvastatin (713) 713
drug interactions (711) 711
internal medicine (711) 711
cholesterol - blood (702) 702
double-blind method (701) 701
dyslipidemias - drug therapy (699) 699
safety (683) 683
follow-up studies (676) 676
health aspects (663) 663
anticholesteremic agents - adverse effects (631) 631
hyperlipidemias - drug therapy (630) 630
rosuvastatin calcium (630) 630
heptanoic acids - therapeutic use (622) 622
clinical trials (620) 620
pyrroles - therapeutic use (613) 613
coronary heart disease (610) 610
low density lipoproteins (604) 604
diabetes (598) 598
hydroxymethylglutaryl-coa reductase inhibitors (597) 597
lipids - blood (595) 595
muscular diseases - chemically induced (590) 590
statin therapy (564) 564
biomarkers - blood (555) 555
coa reductase inhibitors (550) 550
antilipemic agents (540) 540
hypolipidemic agents - therapeutic use (538) 538
inflammation (523) 523
simvastatin - therapeutic use (523) 523
secondary prevention (521) 521
efficacy (519) 519
cholesterol, hdl - blood (516) 516
surgery (511) 511
primary prevention (510) 510
dosage and administration (509) 509
density-lipoprotein cholesterol (504) 504
heart attacks (502) 502
events (493) 493
triglycerides - blood (489) 489
clinical trials as topic (482) 482
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10402) 10402
German (121) 121
Spanish (84) 84
French (81) 81
Japanese (43) 43
Italian (32) 32
Russian (23) 23
Dutch (19) 19
Chinese (18) 18
Swedish (17) 17
Polish (16) 16
Hungarian (15) 15
Portuguese (15) 15
Norwegian (13) 13
Czech (11) 11
Danish (11) 11
Finnish (8) 8
Croatian (6) 6
Turkish (6) 6
Hebrew (3) 3
Korean (2) 2
Slovak (2) 2
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Liver | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
BMJ : British Medical Journal, ISSN 0959-8138, 5/2013, Volume 346, Issue 7911, pp. 14 - 14
Objective To examine the risk of new onset diabetes among patients treated with different HMG-CoA reductase inhibitors (statins).Design Population based cohort... 
RESEARCH | Secondary prevention | Depopulation | Population growth | Diabetes | Older adults | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | THERAPY | EVENTS | CHOLESTEROL | CORONARY | DISEASE | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | MELLITUS | ATORVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Male | Fluorobenzenes - administration & dosage | Heptanoic Acids - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Cardiovascular Diseases - epidemiology | Heptanoic Acids - administration & dosage | Pravastatin - adverse effects | Pyrroles - adverse effects | Diabetes Mellitus, Type 2 - etiology | Female | Retrospective Studies | Odds Ratio | Dyslipidemias - drug therapy | Pyrimidines - administration & dosage | Simvastatin - administration & dosage | Proportional Hazards Models | Rosuvastatin Calcium | Treatment Outcome | Atorvastatin Calcium | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Pravastatin - administration & dosage | Ontario - epidemiology | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Aged | Fluorobenzenes - adverse effects | Diabetes Mellitus, Type 2 - chemically induced | Population Surveillance | Sulfonamides - administration & dosage | Cohort Studies | Inhibitor drugs | Risk assessment | Statins | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
by Swerdlow, Daniel I, Dr|Preiss, David, Dr|Kuchenbaecker, Karoline B, MSc|Holmes, Michael V, PhD|Engmann, Jorgen E L, MSc|Shah, Tina, PhD|Sofat, Reecha, MD|Stender, Stefan, MD|Johnson, Paul C D, PhD|Scott, Robert A, PhD|Leusink, Maarten, MSc|Verweij, Niek, MD|Sharp, Stephen J, MSc|Guo, Yiran, PhD|Giambartolomei, Claudia, MSc|Chung, Christina, MSc|Peasey, Anne, PhD|Amuzu, Antoinette, MSc|Li, KaWah, MSc|Palmen, Jutta, MSc|Howard, Philip, MSc|Cooper, Jackie A, MSc|Drenos, Fotios, PhD|Li, Yun R, BSc|Lowe, Gordon, Prof|Gallacher, John, PhD|Stewart, Marlene C W, PhD|Tzoulaki, Ioanna, PhD|Buxbaum, Sarah G, PhD|van der A, Daphne L, PhD|Forouhi, Nita G, MRCP|Onland-Moret, N Charlotte, PhD|van der Schouw, Yvonne T, Prof|Schnabel, Renate B, MD|Hubacek, Jaroslav A, PhD|Kubinova, Ruzena, MD|Baceviciene, Migle, MD|Tamosiunas, Abdonas, Prof|Pajak, Andrzej, Prof|Topor-Madry, Romanvan, MD|Stepaniak, Urszula, PhD|Malyutina, Sofia, Prof|Baldassarre, Damiano, PhD|Sennblad, Bengt, PhD|Tremoli, Elena, Prof|de Faire, Ulf, Prof|Veglia, Fabrizio, PhD|Ford, Ian, Prof|Jukema, J Wouter, Prof|Westendorp, Rudi G J, Prof|de Borst, Gert Jan, MD|de Jong, Pim A, MD|Algra, Ale, Prof|Spiering, Wilko, MD|der Zee, Anke H Maitland-van, PhD|Klungel, Olaf H, PharmD|de Boer, Anthonius, Prof|Doevendans, Pieter A, Prof|Eaton, Charles B, Prof|Robinson, Jennifer G, Prof|Duggan, David, PhD|Kjekshus, John, Prof|Downs, John R, MD|Gotto, Antonio M, MD|Keech, Anthony C, MD|Marchioli, Roberto, MD|Tognoni, Gianni, MD|Sever, Peter S, Prof|Poulter, Neil R, Prof|Waters, David D, MD|Pedersen, Terje R, MD|Amarenco, Pierre, MD|Nakamura, Haruo, MD|McMurray, John J V, Prof|Lewsey, James D, PhD|Chasman, Daniel I, PhD|Ridker, Paul M, MD|Maggioni, Aldo P, Prof|Tavazzi, Luigi, Prof|Ray, Kausik K, Prof|Seshasai, Sreenivasa Rao Kondapally, MD|Manson, JoAnn E, Prof|Price, Jackie F, MD|Whincup, Peter H, Prof|Morris, Richard W, Prof|Lawlor, Debbie A, Prof|Smith, George Davey, Prof|Ben-Shlomo, Yoav, Prof|Schreiner, Pamela J, Prof|Fornage, Myriam, Prof|Siscovick, David S, Prof|Cushman, Mary, MD|Kumari, Meena, PhD|Wareham, Nick J, Prof|Verschuren, W M Monique, PhD|Redline, Susan, Prof|Patel, Sanjay R, MD|Whittaker, John C, Prof|Hamsten, Anders, Prof|Delaney, Joseph A, PhD|Dale, Caroline, PhD|Gaunt, Tom R, PhD|Wong, Andrew, PhD|Kuh, Diana, Prof|Hardy, Rebecca, Prof|Kathiresan, Sekar, MD|Castillo, Berta A, PhD|van der Harst, Pim, Prof|Brunner, Eric J, Prof|Tybjaerg-Hansen, Anne, Prof|Marmot, Michael G, Prof|Krauss, Ronald M, MD|Tsai, Michael, Prof|Coresh, Josef, Prof|Hoogeveen, Ronald C, PhD|Psaty, Bruce M, Prof|Lange, Leslie A, PhD|Hakonarson, Hakon, Prof|Dudbridge, Frank, PhD|Humphries, Steve E, Prof|Talmud, Philippa J, Prof|Kivimäki, Mika, Prof|Timpson, Nicholas J, PhD|Langenberg, Claudia, MD|Asselbergs, Folkert W, MD|Voevoda, Mikhail, Prof|Bobak, Martin, Prof|Pikhart, Hynek, PhD|Wilson, James G, Prof|Reiner, Alex P, Prof|Keating, Brendan J, PhD|Hingorani, Aroon D, Prof|Sattar, Naveed, Prof and MAGIC Consortium and InterAct Consortium and DIAGRAM Consortium
The Lancet, ISSN 0140-6736, 01/2015, Volume 385, Issue 9965, pp. 351 - 361
Summary Background Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to assess whether this increase in risk is a consequence of... 
Internal Medicine | LDL CHOLESTEROL | MEDICINE, GENERAL & INTERNAL | HIGH-DOSE ATORVASTATIN | METAANALYSIS | STATIN THERAPY | ASSOCIATION ANALYSES | DISEASE | PREVENTION | BODY-MASS INDEX | RISK | MENDELIAN RANDOMIZATION | Type 2 diabetes | Genetic research | Enzymes | Thiols | Diabetes | Low density lipoprotein | Statins | Cholesterol | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article